Creating sustainable European health-care systems through the increased use of generic medicines: A policy analysis

Journal of Generic Medicines

Volumn 7, Issue 2, 2010, Pages 131-137

  Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Europe; Generic medicines; Health policy; Health care system; Sustainability

Indexed keywords

GENERIC DRUG;

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RELEASE; EUROPE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; PATENT; PEER REVIEW; PHARMACEUTICAL CARE; PRESCRIPTION; REVIEW;

EID: 77951806024     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2010.8     Document Type: Review

References (14)

1. European Commission. (2007) Pharmaceutical Forum: First Progress Report, 29th of September 2006, Brussels, Belgium: European Commission, http://ec.europa.eu/health/ph-overview/other-policies/pharmaceutical/ pharma-forum-progres-report092006-en. pdf, accessed 18 August 2009.
2. European Generic Medicines Association Health Economics Committee. (2009) How to Increase Patient Access to Generic Medicines in European Healthcare Systems, Brussels, Belgium: European Generic Medicines Association http://www.egagenerics.com/doc/ega-increase-patient-access-update-072009.pdf, accessed 17 August 2009.
3. European Commission. (2004) Innovation in the Pharmaceutical Sector, Brussels, Belgium: Charles River Associates, http://pharmacos.eudra.org, accessed 17 August 2009.
4. European Commission. (2008) Pharmaceutical Sector Inquiry Preliminary Report, Brussels, Belgium: European Commission, http://ec.europa.eu/competition/ sectors/pharmaceuticals/inquiry/preliminary-report.pdf, accessed 18 August 2009.
5. Simoens, S. and De Coster, S. (2006) Sustaining Generic Medicines Markets in Europe, Brussels, Belgium: European Generic Medicines Association, http://www.egagenerics.com, accessed 14 August 2009.
6. European Generic Medicines Association. (2007) 2007 Market Review. Brussels, Belgium: European Generic Medicines Association.
7. G10 High Level Group on Innovation and Provision of Medicines in the European Union. (2002) Recommendations for Action, Brussels, Belgium: European Commission, http://europa.eu.int/comm/health/ph-overview/Documents/key08-en. pdf, accessed 14 August 2009.
8. Simoens, S., De Bruyn, K., Bogaert, M. and Laekeman, G. (2005) Pharmaceutical policy regarding generic drugs in Belgium. Pharmacoeconomics 23 (8) : 755-766. (Pubitemid 41420423)
9. Simoens, S. (2009) The Portuguese generic medicines market: A policy analysis. Pharmacy Practice 7 (2) : 74-80.
10. Busse, R. and Riesberg, A. (2004) Health Care Systems in Transition: Germany. Copenhagen, Denmark: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies.
11. Health and Social Care Information Centre. (2009) Prescriptions dispensed in the community: statistics for 1998 to 2008: England, Leeds, UK: Health and Social Care Information Centre, http://www.ic.nhs.uk/statistics-and-data- collections/primary-care/prescriptions/prescriptions-dispensed-in-thecommunity- statistics-for-1998-to-2008:-england, accessed 14 August 2009.
12. Ghislandi, S., Krulichova, I. and Garattini, L. (2005) Pharmaceutical policy in Italy: Towards a structural change? Health Policy 72 (1) : 53-63. (Pubitemid 40349008)
13. Danish Medicine Agency. (2006) The Use of ' not S ' in 2005. Copenhagen, Denmark: Danish Medicines Agency.
14. INFARMED. (2006) Estudo de Opiniãosobre Medicamentos Genéricos (Study of the Opinion about Generic Medicines), Lisbon, Portugal: INFARMED, http://www.infarmed.pt/portal/page/portal/INFARMED, accessed 17 August 2009.